ArticleOncoTargets and therapy2019

Silencing stomatin-like protein 2 attenuates tumor progression and inflammatory response through repressing CD14 in liver cancer.

Xiaolin Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.